Telomir Pharmaceuticals reported total assets of $5.37M and total liabilities of $0.33M for the quarter ended Jun 2026, up 992.4% year over year. This balance sheet covers 14 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash & EquivalentsCash & Equiv. | 0.00M | 0.00M | 0.01M | 0.00M | 0.00M | 3.30M | 1.90M | 0.83M | 1.27M | 0.40M | 0.75M | 7.33M | 7.29M | 5.20M |
| Receivables - OtherOther Receivables | 0.13M | 0.13M | 0.13M | 0.13M | 0.32M | 526.00 | ||||||||
| Prepaid Assets | 713.00 | 0.10M | 0.09M | 0.08M | 0.06M | 0.09M | 0.08M | 0.07M | 0.05M | 0.20M | ||||
| Current Assets | 0.05M | 0.44M | 3.50M | 2.10M | 1.04M | 1.32M | 0.49M | 0.83M | 7.40M | 7.34M | 5.37M | |||
| Non-Current Assets | ||||||||||||||
| Other Non-Current Assets | 0.05M | 4.34M | ||||||||||||
| Non-Current Assets | 4.34M | |||||||||||||
| Assets | 0.05M | 4.77M | 3.50M | 2.10M | 1.04M | 1.32M | 0.49M | 0.83M | 7.40M | 7.34M | 5.37M | |||
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payables | 0.40M | 0.71M | 0.48M | 0.39M | 0.51M | 0.59M | 0.56M | 0.25M | 0.33M | 0.54M | 0.20M | |||
| Payables | 0.40M | 0.71M | 0.48M | 0.39M | 0.51M | 0.59M | 0.56M | 0.25M | 0.33M | 0.54M | 0.20M | |||
| Other Accumulated Expenses | 0.53M | 0.09M | 0.10M | 0.10M | 0.10M | 0.32M | 526.00 | |||||||
| Short term Debt | 0.10M | 0.14M | ||||||||||||
| Total Current Liabilities | 0.99M | 1.34M | 0.49M | 0.53M | 0.60M | 0.68M | 0.65M | 0.35M | 0.42M | 1.43M | 0.33M | |||
| Non-Current Liabilities | ||||||||||||||
| Other Non-Current Liabilities | 0.58M | 0.53M | 0.01M | 0.14M | 0.09M | 0.50M | ||||||||
| Total Non-Current Liabilities | 0.40M | 0.81M | 0.48M | 0.33M | 0.51M | 0.18M | ||||||||
| Total Liabilities | 0.99M | 1.34M | 0.49M | 0.47M | 0.60M | 0.68M | 0.65M | 0.35M | 0.42M | 1.43M | 0.33M | |||
| Shareholder's Equity | ||||||||||||||
| Total Debt | 0.10M | 0.14M | ||||||||||||
| Common Equity | -0.94M | -0.51M | 3.89M | 2.18M | 3.44M | 3.02M | 1.63M | 0.44M | 0.64M | -0.16M | 0.48M | 6.98M | 5.91M | 5.03M |
| Liabilities and Shareholders Equity | 0.05M | 4.77M | 3.50M | 2.10M | 1.04M | 1.32M | 0.49M | 0.83M | 7.40M | 7.34M | 5.37M | |||
| Retained Earnings | -0.99M | -14.06M | -20.32M | -21.77M | -27.70M | -30.60M | -32.78M | -37.85M | -38.95M | -41.01M | -43.72M |
Pull Telomir Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=TELO&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "TELO", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=TELO&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();